DE3781667D1 - Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns. - Google Patents

Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns.

Info

Publication number
DE3781667D1
DE3781667D1 DE8787311466T DE3781667T DE3781667D1 DE 3781667 D1 DE3781667 D1 DE 3781667D1 DE 8787311466 T DE8787311466 T DE 8787311466T DE 3781667 T DE3781667 T DE 3781667T DE 3781667 D1 DE3781667 D1 DE 3781667D1
Authority
DE
Germany
Prior art keywords
dihydroxycholecalciferol
prevent bone
bone age
age
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787311466T
Other languages
English (en)
Other versions
DE3781667T2 (de
Inventor
Yuji Maeda
Hideyuki Yamato
Toru Hirai
Masanori Ikuzawa
Mikio Matsuki
Masanori Togawa
Eiji Inoguchi
Sinji Nakajima
Tadaaki Kato
Chikao Yoshikumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP30939286A external-priority patent/JPS63166830A/ja
Priority claimed from JP30939386A external-priority patent/JPS63166829A/ja
Application filed by Kureha Corp filed Critical Kureha Corp
Application granted granted Critical
Publication of DE3781667D1 publication Critical patent/DE3781667D1/de
Publication of DE3781667T2 publication Critical patent/DE3781667T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8787311466T 1986-12-29 1987-12-24 Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns. Expired - Fee Related DE3781667T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30939286A JPS63166830A (ja) 1986-12-29 1986-12-29 老化防止剤
JP30939386A JPS63166829A (ja) 1986-12-29 1986-12-29 骨強度増強剤

Publications (2)

Publication Number Publication Date
DE3781667D1 true DE3781667D1 (de) 1992-10-15
DE3781667T2 DE3781667T2 (de) 1993-01-28

Family

ID=26565939

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787311466T Expired - Fee Related DE3781667T2 (de) 1986-12-29 1987-12-24 Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns.

Country Status (3)

Country Link
US (1) US5001118A (de)
EP (1) EP0276573B1 (de)
DE (1) DE3781667T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
US5116828A (en) * 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
AU666529B2 (en) * 1992-04-24 1996-02-15 Wisconsin Alumni Research Foundation Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
KR960013798B1 (ko) * 1992-04-24 1996-10-10 재단법인 한국전자통신연구소 평면 도파로형 공간 스위치
JP2876547B2 (ja) * 1992-06-23 1999-03-31 呉羽化学工業株式会社 抗クル病剤
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
US6416737B1 (en) 1998-11-19 2002-07-09 Board Of Trustees Of The University Of Arkansas Increasing bone strength with selected bisphosphonates
FR2814369B1 (fr) * 2000-09-27 2004-05-21 Spmd Preparation medicamenteuse a base de vitamines d3 et son procede de fabrication

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715374A (en) * 1972-05-05 1973-02-06 Wisconsin Alumni Res Found 24,25-dihydroxycholecalciferol
US3994878A (en) * 1975-10-10 1976-11-30 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol and alkanoyl derivatives thereof
DE3064789D1 (en) * 1979-02-15 1983-10-20 Teijin Ltd New 25-hydroxy-24-oxocholestane derivatives and preparation thereof
US4230701A (en) * 1979-03-21 1980-10-28 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
US4338250A (en) * 1981-04-27 1982-07-06 Wisconsin Alumni Research Foundation 1-Hydroxylation process
US4442093A (en) * 1981-05-15 1984-04-10 Kureha Kagaku Kogyo Kabushiki Kaisha Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
US4456553A (en) * 1982-05-07 1984-06-26 Teijin Limited Vitamin D3 derivatives, process for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom
JPS6011422A (ja) * 1983-06-30 1985-01-21 Kureha Chem Ind Co Ltd 抗筋ジストロフイ−症剤
US4501738A (en) * 1983-06-30 1985-02-26 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases
JPS6089422A (ja) * 1983-10-24 1985-05-20 Kureha Chem Ind Co Ltd 抗骨粗鬆症剤
JPS61129130A (ja) * 1984-11-27 1986-06-17 Kureha Chem Ind Co Ltd 抗尿毒症剤

Also Published As

Publication number Publication date
DE3781667T2 (de) 1993-01-28
EP0276573A2 (de) 1988-08-03
US5001118A (en) 1991-03-19
EP0276573A3 (en) 1988-10-12
EP0276573B1 (de) 1992-09-09

Similar Documents

Publication Publication Date Title
DE3772121D1 (de) Abtastendoskop zur chirurgischen verwendung.
DE3777397D1 (de) Knochenimplantat.
DE3687069D1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DE3773965D1 (de) Sehnen-prothese.
DE3787077D1 (de) Knochenimplantat.
DK132088D0 (da) Knogledensitometer
DE3584013D1 (de) Zubereitung zur behandlung von psoriasis.
DE3786641D1 (de) Einheit zur aufnahme von blutbestandteilen.
DE3761254D1 (de) Fraktionierung von fettmischungen.
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
DE3685633D1 (de) Behandlung von knochenstoerungen.
DE3788515D1 (de) Bestimmung von biomasse.
DE3789559D1 (de) Menschlicher präproinsulinähnlicher Wachstumsfaktor I.
DE3782028D1 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE3789316D1 (de) Herstellung von human-parathyroidhormon.
DE3766730D1 (de) Herstellung von silo-viehfutter.
DE3669994D1 (de) Knochenimplantat.
DE68901294D1 (de) Katalysator zur wasserstoffbehandlung von kohlenwasserstoffen.
DE3775192D1 (de) Zusatz von calciumverbindungen in der karbothermischen reduktion von kieselerde.
DE3781667D1 (de) Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns.
DE3764838D1 (de) Methode zur herstellung von aktiven antioxidanzien.
DE3778296D1 (de) Verhinderung von biologischem bewuchs mit bestimmten alkylthioalkylaminen.
DE69002139D1 (de) Kosmetische verwendung von 3-indolbrenztraubensaeure.
DE3765250D1 (de) Verwendung von 24,25-dihydroxycholecalciferol zur behandlung von harnsteinen.
DE3751059D1 (de) Verwendung von Corticosteroide zur Verringerung von postoperativen Schmerzen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee